Discover Novo's pipeline in 2026, as it recently set out a new plan to reach $23 billion in risk-adjusted pipeline sales by ...

Learn when TIDE-based Sanger sequencing can replace NGS for measuring on-target gene editing efficiency in regulated ...

Delve into the field of B7-H3 ADCs, a new contender in SCLC cancer, as Hansoh Pharma and Medilink bring momentum with ...

Explore the preclinical research catching our eye in October 2026, from AI drug design to small molecules and gene therapy ...

Three big bets in metabolic disease: the race to challenge Lilly and Novo, a pill that mimics exercise, and a gene therapy ...

Artificial intelligence (AI) has taken the biotech industry by storm, leading to numerous AI drug discovery companies operating in the field, as the technology enables them to speed up the drug ...

Keep up with biotech layoffs in 2026! Each week, the Labiotech team tracks and analyzes layoffs across the biotech industry, offering a clear, data-driven view of trends affecting companies, ...